{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:03:38Z","timestamp":1790737418537,"version":"4.1.0"},"reference-count":168,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.rdc.2013.10.005","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T06:15:53Z","timestamp":1383632153000},"page":"27-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cardiovascular Disease in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"40","author":[{"given":"Deepali","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Gonz\u00e1lez-Mayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard D.","family":"Brasington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.10.005_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/03009747609099912","article-title":"Causes of death in autopsied RA patients","volume":"5","author":"Mutru","year":"1976","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.005_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/03009742.2012.723747","article-title":"Cardiovascular diseases in patients with rheumatoid arthritis","volume":"42","author":"Koivuniemi","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7861\/clinmedicine.1-1-18","article-title":"Cardiac involvement in rheumatoid arthritis","volume":"1","author":"Kitas","year":"2001","journal-title":"Clin Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/oxfordjournals.eurheartj.a060892","article-title":"Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease","volume":"16","author":"Corrao","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.rdc.2013.10.005_bib5","first-page":"921","article-title":"The heart in rheumatoid arthritis: a clinical and echocardiographic study","volume":"65","author":"Mody","year":"1987","journal-title":"Q\u00a0J Med"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib6","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.ijcard.2013.01.064","article-title":"Cholesterol pericarditis associated with rheumatoid arthritis: a rare cause of pericardial effusion","volume":"166","author":"Barcin","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0049-0172(90)90056-L","article-title":"Cardiac compression in rheumatoid pericarditis","volume":"20","author":"Escalante","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/03009742.2012.695803","article-title":"Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors","volume":"41","author":"Nyh\u00e4ll-W\u00e5hlin","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib9","first-page":"660","article-title":"Anti-TNF alpha therapy does not always protect rheumatoid arthritis patients against developing pericarditis","volume":"25","author":"Ambrose","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib10","first-page":"17","article-title":"Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis","volume":"6","author":"Nagyhegyi","year":"1988","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01450894","article-title":"Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease","volume":"17","author":"Wis\u0142owska","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1529-0131(200104)45:2<129::AID-ANR164>3.0.CO;2-K","article-title":"Cardiac manifestations of rheumatoid arthritis: a case control transesophageal echocardiography study in 30 patients","volume":"45","author":"Guedes","year":"2001","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib13","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amjcard.2007.03.048","article-title":"Characterization of valvular heart disease in rheumatoid arthritis by transesophageal echocardiography and clinical correlates","volume":"100","author":"Roldan","year":"2007","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib14","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.ijcard.2012.05.057","article-title":"Heart involvement in rheumatoid arthritis: systematic review and meta-analysis","volume":"167","author":"Corrao","year":"2013","journal-title":"Int J Cardiol"},{"issue":"5\u20136","key":"10.1016\/j.rdc.2013.10.005_bib15","first-page":"163","article-title":"Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis","volume":"18","author":"Wis\u0142owska","year":"1999","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3899\/jrheum.100844","article-title":"Relationship between cardiac valvular and arterial calcification in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"38","author":"Yiu","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy","volume":"116","author":"Wolfe","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.005_bib19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.005_bib20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3899\/jrheum.100979","article-title":"The influence of rheumatoid arthritis disease characteristics on heart failure","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2362.1993.tb00769.x","article-title":"Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease","volume":"23","author":"Mustonen","year":"1993","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rdc.2013.10.005_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/acr.20425","article-title":"Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2362.1996.133284.x","article-title":"Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease","volume":"26","author":"Corrao","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rdc.2013.10.005_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/art.24148","article-title":"Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction","volume":"60","author":"Rudominer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10067-007-0820-x","article-title":"Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up","volume":"27","author":"Yazici","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.005_bib26","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1136\/ard.2009.124362","article-title":"Increased prevalence of diastolic dysfunction in rheumatoid arthritis","volume":"69","author":"Liang","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/j.semarthrit.2003.09.011","article-title":"Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease","volume":"33","author":"Gonzalez-Juanatey","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acr.21861","article-title":"Diastolic dysfunction in rheumatoid arthritis. A meta-analysis and systematic review","volume":"65","author":"Aslam","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2013.10.005_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/hrt.2009.177980","article-title":"Progression of preclinical diastolic dysfunction to the development of symptoms","volume":"96","author":"Correa de Sa","year":"2010","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.005_bib30","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/art.24795","article-title":"A\u00a0meta-analysis of the effect size of rheumatoid arthritis on left ventricular mass: comment on the article by Rudominer et\u00a0al","volume":"60","author":"Corrao","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib31","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.27349","article-title":"Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.005_bib32","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.30323","article-title":"Signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis","volume":"63","author":"Davis","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.005_bib33","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1186\/ar3752","article-title":"Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study","volume":"14","author":"Giles","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.005_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000094079","article-title":"Cardiomyopathy related to antimalarial therapy with illustrative case report","volume":"107","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Cardiology"},{"key":"10.1016\/j.rdc.2013.10.005_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.semarthrit.2003.09.012","article-title":"Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature","volume":"33","author":"Nord","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.euje.2006.02.002","article-title":"Hydroxychloroquine-induced restrictive cardiomyopathy","volume":"8","author":"Cotroneo","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.rdc.2013.10.005_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3899\/jrheum.080305","article-title":"Restrictive cardiomyopathy secondary to hydroxychloroquine therapy","volume":"36","author":"Manohar","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib38","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIRCHEARTFAILURE.110.959916","article-title":"Hydroxychloroquine-induced cardiomyopathy: a case report","volume":"4","author":"Muthukrishnan","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.rdc.2013.10.005_bib39","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMcpc1011319","article-title":"Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure","volume":"364","author":"Newton-Cheh","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12471-011-0185-2","article-title":"Acute left ventricular failure in a patient with hydroxychloroquine-induced cardiomyopathy","volume":"19","author":"Hartmann","year":"2011","journal-title":"Neth Heart J"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.005_bib41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/RHU.0b013e31826852db","article-title":"Fatal antimalarial-induced cardiomyopathy: report of 2 cases","volume":"18","author":"Azimian","year":"2012","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib42","first-page":"77","article-title":"Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy","volume":"2","author":"Joyce","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"14","key":"10.1016\/j.rdc.2013.10.005_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/0961203312462757","article-title":"Evidence for risk of cardiomyopathy with hydroxychloroquine","volume":"21","author":"Sumpter","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2013.10.005_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1053-2498(03)00108-6","article-title":"Heart transplantation in a patient with\u00a0chloroquine-induced cardiomyopathy","volume":"23","author":"Freihage","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.rdc.2013.10.005_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib46","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hc3501.096063","article-title":"Anti-tumor necrosis factor-{alpha} antibody limits heart failure in a transgenic model","volume":"104","author":"Kadokami","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib47","doi-asserted-by":"crossref","first-page":"12746","DOI":"10.1073\/pnas.97.23.12746","article-title":"Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.rdc.2013.10.005_bib48","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1161\/01.CIR.99.25.3224","article-title":"A\u00a0phase I trial of tumor necrosis factor receptor (p75) fusion protein (TNFR: Fc) in patients with advanced heart failure","volume":"99","author":"Deswal","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib49","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.rdc.2013.10.005_bib50","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","article-title":"Case reports of heart failure after therapy with a tumor necrosis factor antagonist","volume":"138","author":"Kwon","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib52","first-page":"1213","article-title":"Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib53","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib54","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2006.067660","article-title":"All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists","volume":"66","author":"Carmona","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/art.23281","article-title":"Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?","volume":"58","author":"Listing","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00296-006-0215-3","article-title":"The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran\u2019s Affairs patients receiving tumor necrosis factor \u03b1 antagonists","volume":"27","author":"Cole","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2013.10.005_bib57","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor \u03b1 therapy and cardiovascular events in rheumatoid arthritis","volume":"4","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib58","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/13506129.2012.736438","article-title":"Amyloid A deposition in rheumatoid arthritis: a retrospective clinicopathologic study of 161 autopsy patients","volume":"19","author":"Bely","year":"2012","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib59","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/13506120802524676","article-title":"Amyloidosis is frequently undetected in patients with rheumatoid","volume":"15","author":"Koivuniemi","year":"2008","journal-title":"Amyloid"},{"key":"10.1016\/j.rdc.2013.10.005_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ard.61.1.42","article-title":"Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics","volume":"61","author":"El Mansoury","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib61","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/PL00011217","article-title":"Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis","volume":"21","author":"Kuroda","year":"2002","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.005_bib62","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3899\/jrheum.111453","article-title":"Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis","volume":"39","author":"Kuroda","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.005_bib63","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3899\/jrheum.090101","article-title":"Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosalamyloid deposits in reactive amyloidosis associated with rheumatoid arthritis","volume":"36","author":"Kuroda","year":"2009","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.1700760126","article-title":"Heart lesions in rheumatoid disease","volume":"76","author":"Cruickshank","year":"1958","journal-title":"J\u00a0Pathol Bacteriol"},{"key":"10.1016\/j.rdc.2013.10.005_bib65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/0003-4819-58-1-102","article-title":"The heart in rheumatoid arthritis: a clinical and pathological study of 62 cases","volume":"58","author":"Lebowitz","year":"1963","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.005_bib66","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1136\/ard.45.11.963","article-title":"Coronary arteritis complicating rheumatoid arthritis","volume":"45","author":"van Albada-Kuipers","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib67","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib68","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2005.037978","article-title":"Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome","volume":"65","author":"Douglas","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.005_bib69","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/art.21932","article-title":"Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis","volume":"54","author":"Van Doornum","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.rdc.2013.10.005_bib70","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A\u00a0tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib71","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2009.122374","article-title":"Total cholesterol and LDL levels decrease before rheumatoid arthritis","volume":"69","author":"Myasoedova","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib72","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar2471","article-title":"Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis","volume":"10","author":"Hahn","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.005_bib74","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/art.24802","article-title":"Abnormal function of high density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis","volume":"60","author":"Charles-Schoeman","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib75","first-page":"482","article-title":"Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis","volume":"23","author":"Wada","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib76","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib77","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation","volume":"25","author":"Dursuno\u011flu","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rdc.2013.10.005_bib78","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","article-title":"Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study","volume":"113","author":"Park","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib79","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"Boers","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib80","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.20393","article-title":"Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients","volume":"63","author":"Morris","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib81","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.semarthrit.2011.04.003","article-title":"The effect of TNF-\u03b1 blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis","volume":"41","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib82","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib83","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/art.22033","article-title":"Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate","volume":"54","author":"Maini","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib84","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3455","article-title":"Integrated safety in tocilizumab clinical trials","volume":"13","author":"Schiff","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib85","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/acr.21847","article-title":"Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: twenty-four-week results of an open-label, clinical practice study","volume":"65","author":"Weinblatt","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2013.10.005_bib86","unstructured":"Genovese MC, Sebba A, Rubbert-Roth A, et\u00a0al. Long-term safety of tocilizumab in rheumatoid arthritis clinical trials. Presented at ACR [abstract 2217]. Chicago, 2011."},{"key":"10.1016\/j.rdc.2013.10.005_bib87","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"Fleischmann","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib88","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJMoa1112072","article-title":"Tofacitinib or adalimumab versus placebo in rheumatoid arthritis","volume":"367","author":"van Vollenhoven","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9865","key":"10.1016\/j.rdc.2013.10.005_bib89","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","article-title":"Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial","volume":"381","author":"Burmester","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.10.005_bib90","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomized placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.10.005_bib91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3899\/jrheum.110318","article-title":"Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis","volume":"39","author":"Sheng","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib92","first-page":"326258","article-title":"The role of simvastatin in the therapeutic approach of rheumatoid arthritis","volume":"2013","author":"Cojocaru","year":"2013","journal-title":"Autoimmune Dis"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.005_bib93","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/ard.2003.018333","article-title":"Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis","volume":"63","author":"Van Doornum","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib94","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jacc.2004.11.006","article-title":"Simvastatin improves endothelial function in patients with rheumatoid arthritis","volume":"45","author":"Hermann","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.005_bib95","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jacc.2007.04.076","article-title":"Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis","volume":"50","author":"Maki-Petaja","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.rdc.2013.10.005_bib96","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/ard.2010.142455","article-title":"Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study","volume":"70","author":"De Vera","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib97","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/rheumatology\/kem169","article-title":"Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis","volume":"46","author":"Panoulas","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.10.005_bib98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.rdc.2013.10.005_bib99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semarthrit.2011.07.004","article-title":"Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"41","author":"Chung","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib100","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib101","first-page":"469","article-title":"Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older","volume":"34","author":"Simard","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib102","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","article-title":"Cardiovascular risk factors in women with and without rheumatoid arthritis","volume":"50","author":"Solomon","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.005_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3132\/dvdr.2007.031","article-title":"Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis","volume":"4","author":"La Montagna","year":"2007","journal-title":"Diab Vasc Dis Res"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.005_bib104","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis","volume":"196","author":"Chung","year":"2008","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.005_bib105","first-page":"1403","article-title":"Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis","volume":"30","author":"Dessein","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib106","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib107","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","author":"Kern","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.005_bib108","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI118504","article-title":"The expression of TNF alpha by human muscle. Relationship to insulin resistance","volume":"97","author":"Saghizadeh","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.rdc.2013.10.005_bib109","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1073\/pnas.91.11.4854","article-title":"Tumor necrosis factor alpha inhibits signaling from the insulin receptor","volume":"91","author":"Hotamisligil","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.005_bib110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1161\/01.ATV.18.8.1199","article-title":"Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rdc.2013.10.005_bib111","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.005_bib112","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/art.38071","article-title":"Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis","volume":"65","author":"Crowson","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.005_bib113","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/art.20612","article-title":"Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis","volume":"50","author":"Maradit-Kremers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-3083.1997.d01-366.x","article-title":"Smoking and immunity: an additional player in the mosaic of autoimmunity","volume":"45","author":"George","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.rdc.2013.10.005_bib115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.amjmed.2005.09.053","article-title":"Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women","volume":"119","author":"Costenbader","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib116","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","article-title":"Cigarette smoking and rheumatoid arthritis severity","volume":"56","author":"Saag","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib117","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.atherosclerosis.2004.11.026","article-title":"Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men","volume":"181","author":"Helmersson","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.rdc.2013.10.005_bib118","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1196\/annals.1361.069","article-title":"Early atherosclerosis in rheumatoid arthritis: effect of smoking on thickness of the carotid artery intima media","volume":"1051","author":"Gerli","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.rdc.2013.10.005_bib119","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.23650","article-title":"High ten year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients","volume":"58","author":"Maradit-Kremers","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/rheumatology\/kel253","article-title":"Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis","volume":"46","author":"Young","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2013.10.005_bib121","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/art.10419","article-title":"Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients","volume":"46","author":"Goodson","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib122","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semarthrit.2007.09.008","article-title":"Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients","volume":"38","author":"Georgiadis","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib123","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2323","article-title":"Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation","volume":"9","author":"Hannawi","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.005_bib124","first-page":"61","article-title":"Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis","volume":"35","author":"Kao","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.005_bib125","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/art.21288","article-title":"Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors","volume":"52","author":"Chung","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.054445","article-title":"Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.005_bib127","first-page":"2089","article-title":"The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis","volume":"32","author":"Sihvonen","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.2007.073718","article-title":"Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"67","author":"Gerli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib129","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib130","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.22527","article-title":"Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study","volume":"56","author":"Mattey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.22482","article-title":"HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis","volume":"57","author":"Gonzalez-Gay","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib132","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/art.21204","article-title":"Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort","volume":"52","author":"Goodson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.10.005_bib133","doi-asserted-by":"crossref","first-page":"e6242","DOI":"10.1371\/journal.pone.0006242","article-title":"Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis","volume":"4","author":"Graf","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.005_bib134","first-page":"1219","article-title":"High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis","volume":"32","author":"Gonzalez-Gay","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib135","doi-asserted-by":"crossref","first-page":"456S","DOI":"10.1093\/ajcn\/83.2.456S","article-title":"Inflammation and cardiovascular disease mechanisms","volume":"83","author":"Libby","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.rdc.2013.10.005_bib136","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","article-title":"Interleukin-6 as a key player in systemic inflammation and joint destruction","volume":"8","author":"Fonseca","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rdc.2013.10.005_bib137","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib138","first-page":"241","article-title":"A\u00a0new immunological marker of atherosclerotic injury of arterial wall","volume":"109","author":"Olopien","year":"2001","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"10.1016\/j.rdc.2013.10.005_bib139","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1161\/01.CIR.0000097109.90783.FC","article-title":"Inflammatory markers and onset of cardiovascular events: results from the health ABC study","volume":"108","author":"Cesari","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9149(90)90291-8","article-title":"Detection and localization of tumor necrosis factor in human atheroma","volume":"65","author":"Barath","year":"1990","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.rdc.2013.10.005_bib141","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1161\/CIRCULATIONAHA.110.004671","article-title":"Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study","volume":"123","author":"Schjerning Olsen","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib142","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.005_bib143","first-page":"1589","article-title":"Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction","volume":"32","author":"Hudson","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib144","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/ard.2007.076760","article-title":"Nonsteroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients","volume":"68","author":"Goodson","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib145","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","author":"Lindhardsen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib146","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib147","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","article-title":"Tumor necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis","volume":"70","author":"Greenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib148","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.005_bib149","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","article-title":"Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study","volume":"52","author":"Avi\u00f1a-Zubieta","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.005_bib150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/ard.2010.140210","article-title":"Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study","volume":"70","author":"Avi\u00f1a-Zubieta","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.005_bib151","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","article-title":"Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"110","author":"Crowson","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2013.10.005_bib152","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib153","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/ard.2010.145482","article-title":"Towards improving cardiovascular risk management in patients with RA: need for a accurate risk assessment","volume":"70","author":"Crowson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib154","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ard.2009.115717","article-title":"Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial under treatment of lipid associated cardiovascular risk?","volume":"69","author":"Toms","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib155","first-page":"2095","article-title":"Effects of angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis","volume":"32","author":"Tikiz","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2013.10.005_bib156","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.107.734384","article-title":"Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis","volume":"117","author":"Flammer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib157","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(84)91821-X","article-title":"Captopril: a new treatment for rheumatoid arthritis?","volume":"1","author":"Martin","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.10.005_bib158","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2013.10.005_bib159","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/rheumatology\/kep366","article-title":"The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review","volume":"49","author":"Westlake","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.10.005_bib160","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.005_bib161","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3899\/jrheum.101143","article-title":"Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide","volume":"38","author":"El-Barbary","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.005_bib162","doi-asserted-by":"crossref","first-page":"730.e9","DOI":"10.1016\/j.amjmed.2013.02.016","article-title":"Cardiovascular risk in rheumatoid arthritis: comparing TNF-\u03b1 blockade with nonbiologic DMARDs","volume":"126","author":"Solomon","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2013.10.005_bib163","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trsl.2010.09.005","article-title":"Tumor necrosis factor-alpha blockade, cardiovascular outcomes, and survival in rheumatoid arthritis","volume":"157","author":"Al-Aly","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.rdc.2013.10.005_bib164","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.2010.141523","article-title":"Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study","volume":"70","author":"Provan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib165","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy","volume":"114","author":"Maki-Petaja","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.rdc.2013.10.005_bib166","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/rheumatology\/kep251","article-title":"Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis","volume":"48","author":"Galarraga","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.10.005_bib167","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/ard.2007.086157","article-title":"Infliximab improves vascular stiffness in patients with rheumatoid arthritis","volume":"68","author":"Wong","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2013.10.005_bib168","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:11:36Z","timestamp":1760181096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":168,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0889857X13000926"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.005","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disease in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}